Janes A. Aducanumab: The Controversial New Drug Licensed to Treat Alzheimer’s Disease. TSMJ [Internet]. 2024 Mar. 14 [cited 2024 Nov. 23];22(1):6-11. Available from: https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/2811